A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease

Published:2015-08 Issue:6 Volume:13 Page:235-238
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Targher Giovanni¹,Byrne Christopher D.²³

Affiliation:

1. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

2. Nutrition and Metabolism, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

3. Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/met.2015.1502

Reference44 articles.

1. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

2. Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications

3. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

4. Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes

5. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic lipid droplet-associated proteome changes distinguish dietary-induced fatty liver from glucose tolerance in male mice;American Journal of Physiology-Endocrinology and Metabolism;2024-06-01

2. Deciphering the relational dynamics of AF-2 domain of PAN PPAR through drug repurposing and comparative simulations;PLOS ONE;2023-03-31

3. Hepatic Lipid Droplet-Associated Proteome Changes Distinguish Dietary-Induced Fatty Liver from Insulin Resistance in Male Mice;2023-03-10

4. Association between nonalcoholic fatty liver disease risk scales and metabolic syndrome scales in 418.343 spanish workers;MED BALEAR;2023

5. Alismatis Rhizoma methanolic extract—Effects on metabolic syndrome and mechanisms of triterpenoids using a metabolomic and lipidomic approach;Frontiers in Pharmacology;2022-09-09